We are live on ! Find out more
IRMD icon

iRadimed

112 hedge funds and large institutions have $293M invested in iRadimed in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 36 increasing their positions, 30 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

383% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 6

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

29% more capital invested

Capital invested by funds: $227M → $293M (+$65.5M)

26% more funds holding

Funds holding: 89112 (+23)

20% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 30

2.86% more ownership

Funds ownership: 45.85%48.71% (+2.9%)

Holders
112
Holders Change
+23
Holders Change %
+25.84%
% of All Funds
1.76%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
29
Increased
36
Reduced
30
Closed
6
Calls
$5K
Puts
Net Calls
+$5K
Net Calls Change
+$5K

IRMD Hedge Fund Activity: Q2 2023 in Review

112 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q2 2023, worth a combined $293M — up 29% from $227M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new IRMD positions and 6 closed out — a net gain of 23 holders — while 36 added to existing stakes and 30 trimmed.

The largest buyer was Resource Consulting Group, opening a new position worth an estimated $5.77M. The largest seller was RK Capital Management (Colorado), cutting an estimated $2.13M.

  • 112 institutional investors held iRadimed (IRMD) as of Q2 2023, up from 89 in Q1 2023.
  • Funds reported $293M of iRadimed stock for Q2 2023, up 29% quarter-over-quarter.
  • 29 funds opened new iRadimed positions in Q2 2023 and 6 closed out, a net change of +23 holders.
  • The largest iRadimed buyer in Q2 2023 was Resource Consulting Group, an estimated $5.77M added.
  • The largest iRadimed seller in Q2 2023 was RK Capital Management (Colorado), an estimated $2.13M sold.

Based on aggregated 13F filings for Q2 2023.